178 related articles for article (PubMed ID: 38074684)
1. Structural characterization of human
Yamamoto S; Kono F; Nakatani K; Hirose M; Horii K; Hippo Y; Tamada T; Suenaga Y; Matsuo T
Front Oncol; 2023; 13():1213678. PubMed ID: 38074684
[TBL] [Abstract][Full Text] [Related]
2. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.
Suenaga Y; Nakatani K; Nakagawara A
Jpn J Clin Oncol; 2020 Aug; 50(8):839-846. PubMed ID: 32577751
[TBL] [Abstract][Full Text] [Related]
3. Secondary Structure of Human
Matsuo T; Nakatani K; Setoguchi T; Matsuo K; Tamada T; Suenaga Y
Front Oncol; 2021; 11():688852. PubMed ID: 34497756
[No Abstract] [Full Text] [Related]
4. NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas.
Suenaga Y; Islam SM; Alagu J; Kaneko Y; Kato M; Tanaka Y; Kawana H; Hossain S; Matsumoto D; Yamamoto M; Shoji W; Itami M; Shibata T; Nakamura Y; Ohira M; Haraguchi S; Takatori A; Nakagawara A
PLoS Genet; 2014 Jan; 10(1):e1003996. PubMed ID: 24391509
[TBL] [Abstract][Full Text] [Related]
5.
Mouhand A; Nakatani K; Kono F; Hippo Y; Matsuo T; Barthe P; Peters J; Suenaga Y; Tamada T; Roumestand C
Biomol NMR Assign; 2024 Jun; 18(1):65-70. PubMed ID: 38526839
[TBL] [Abstract][Full Text] [Related]
6. Structural and Functional Characterization of Rv0792c from Mycobacterium tuberculosis: Identifying Small Molecule Inhibitor against HutC Protein.
Chauhan NK; Anand A; Sharma A; Dhiman K; Gosain TP; Singh P; Singh P; Khan E; Chattopadhyay G; Kumar A; Sharma D; Ashish ; Sharma TK; Singh R
Microbiol Spectr; 2023 Feb; 11(1):e0197322. PubMed ID: 36507689
[TBL] [Abstract][Full Text] [Related]
7. Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.
Kaneko Y; Suenaga Y; Islam SM; Matsumoto D; Nakamura Y; Ohira M; Yokoi S; Nakagawara A
Cancer Sci; 2015 Jul; 106(7):840-7. PubMed ID: 25880909
[TBL] [Abstract][Full Text] [Related]
8. NCYM is upregulated by lncUSMycN and modulates N-Myc expression.
Liu PY; Atmadibrata B; Mondal S; Tee AE; Liu T
Int J Oncol; 2016 Dec; 49(6):2464-2470. PubMed ID: 27748806
[TBL] [Abstract][Full Text] [Related]
9. NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells.
Shoji W; Suenaga Y; Kaneko Y; Islam SM; Alagu J; Yokoi S; Nio M; Nakagawara A
Biochem Biophys Res Commun; 2015 Jun; 461(3):501-6. PubMed ID: 25896758
[TBL] [Abstract][Full Text] [Related]
10. TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.
Suenaga Y; Yamamoto M; Sakuma T; Sasada M; Fukai F; Ohira M; Yamaguchi Y; Yamamoto T; Ando K; Ozaki T; Nakagawara A
Biochem Biophys Res Commun; 2019 Oct; 518(2):311-318. PubMed ID: 31427086
[TBL] [Abstract][Full Text] [Related]
11. DNA-duplex linker for AFM-SELEX of DNA aptamer against human serum albumin.
Takenaka M; Okumura Y; Amino T; Miyachi Y; Ogino C; Kondo A
Bioorg Med Chem Lett; 2017 Feb; 27(4):954-957. PubMed ID: 28094182
[TBL] [Abstract][Full Text] [Related]
12. De Novo Evolution of an Antibody-Mimicking Multivalent Aptamer via a DNA Framework.
Tang L; Huang M; Zhang M; Pei Y; Liu Y; Wei Y; Yang C; Xie T; Zhang D; Zhou R; Song Y; Song J
Small Methods; 2023 Jun; 7(6):e2300327. PubMed ID: 37086150
[TBL] [Abstract][Full Text] [Related]
13.
Song M; Li G; Zhang Q; Liu J; Huang Q
Comput Struct Biotechnol J; 2020; 18():3425-3433. PubMed ID: 33294137
[TBL] [Abstract][Full Text] [Related]
14. The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer.
Morozov D; Mironov V; Moryachkov RV; Shchugoreva IA; Artyushenko PV; Zamay GS; Kolovskaya OS; Zamay TN; Krat AV; Molodenskiy DS; Zabluda VN; Veprintsev DV; Sokolov AE; Zukov RA; Berezovski MV; Tomilin FN; Fedorov DG; Alexeev Y; Kichkailo AS
Mol Ther Nucleic Acids; 2021 Sep; 25():316-327. PubMed ID: 34458013
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of protein-DNA complexes using small angle X-ray scattering (SAXS) with contrast variation.
Hutin S; Guillotin A; Zubieta C; Tully MD
Methods Enzymol; 2023; 680():163-194. PubMed ID: 36710010
[TBL] [Abstract][Full Text] [Related]
16. In vitro Selection and Interaction Studies of a DNA Aptamer Targeting Protein A.
Stoltenburg R; Schubert T; Strehlitz B
PLoS One; 2015; 10(7):e0134403. PubMed ID: 26221730
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-Conjugated Innovative 16-mer DNA Aptamer-Based Annexin A1 Targeted Anti-Cancer Drug Delivery.
Bavi R; Hang Z; Banerjee P; Aquib M; Jadhao M; Rane N; Bavi S; Bhosale R; Kodam K; Jeon BH; Gu Y
Mol Ther Nucleic Acids; 2020 Sep; 21():1074-1086. PubMed ID: 32854062
[TBL] [Abstract][Full Text] [Related]
18. Selection of DNA aptamers using atomic force microscopy.
Miyachi Y; Shimizu N; Ogino C; Kondo A
Nucleic Acids Res; 2010 Mar; 38(4):e21. PubMed ID: 19955232
[TBL] [Abstract][Full Text] [Related]
19. Universally Accessible Structural Data on Macromolecular Conformation, Assembly, and Dynamics by Small Angle X-Ray Scattering for DNA Repair Insights.
Chinnam NB; Syed A; Burnett KH; Hura GL; Tainer JA; Tsutakawa SE
Methods Mol Biol; 2022; 2444():43-68. PubMed ID: 35290631
[TBL] [Abstract][Full Text] [Related]
20. Multi-state modeling of antibody-antigen complexes with SAXS profiles and deep-learning models.
Cohen T; Halfon M; Carter L; Sharkey B; Jain T; Sivasubramanian A; Schneidman-Duhovny D
Methods Enzymol; 2023; 678():237-262. PubMed ID: 36641210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
